Filter the directory by category, geography, or sector to find the right partners.
ANJE initiative in southern Portugal providing a 4-month acceleration program with mentoring and business modeling for biotech, agrotech, and ICT startups. Scope: Regional (Alentejo).
BioInnovation Institute is a life science incubator backed by the Novo Nordisk Foundation that helps researchers and founders turn biotech and health innovations into venture ready companies. Based in Copenhagen, BII provides lab space, grant funding, expert business support, and access to investors for projects in therapeutics, diagnostics, and industrial biotech. It runs programs for both idea stage research and early startups, de risking science heavy ventures before they seek larger capital. BII is a central node in the Danish life science startup pipeline.
Generative protein design platform helping scientists engineer new vaccines, therapeutics, and materials.
Organizer of the Lead the Bio Revolution Across Life Science course at DTU.
Life sciences VC founded 2006 investing in biotech and medtech from early to growth stages.
Founded 2008. Specialist VC investing in biotech, pharma, and medical devices with a transatlantic presence.
Organizer of the mRNA-Based Therapeutics Summit Europe series.
Opened 2007. Provides office space, mentorship, and links to Limerick's industry network for medtech, biotech, and digital media startups; supported 50+ firms. Notable alumni include Stokes Bio. Scope: Regional (Mid-West Ireland).
Founded 2008. Active early-stage investor across ICT, biotech, and fintech with multiple fund vehicles.
Four-day leadership masterclass at DTU focused on industrial biotech innovation.
Biotech summit covering R&D and clinical progress in mRNA vaccines and therapeutics.
Novo Holdings is the investment arm of the Novo Nordisk Foundation and the largest life science investor in Denmark. It backs biotech, medtech, and health innovation across seed, venture, and growth stages while also managing the foundation's long term ownership in Novo Nordisk and Novozymes. The firm provides patient capital, deep scientific expertise, and global networks for founders building therapies, diagnostics, and industrial biotech solutions. Novo Holdings is a cornerstone of the Danish life science ecosystem.
Biotech company using AI and genomics to develop RNA therapies targeting chronic liver disease.
Founded 2015. Healthcare and medtech specialist investing across Europe in devices, diagnostics, digital health, and biotech.
A venture fund + angel network based in Szczecin, Pomerangels invests alongside business angels and syndicates in post-revenue companies. With a network of 100+ angels, they co-invest up to €4M in innovative SMEs across ICT, autonomous tech, biotech, etc. Notable focus: companies that already have strong angel syndicates; Pomerangels adds capital on top of angel rounds to scale these ventures.
Founded 2002. Life sciences VC investing in biotech, medtech, and diagnostics across Europe.
Launched 2010 by Wageningen University. Leading agri-foodtech accelerator with EUR 25K non-dilutive funding, a 12-week program, and corporate/research connections; supported 100+ startups like Meatable. Scope: International.
Innovation hub and accelerator supported by Microsoft, nurturing deep-tech startups in biotech, nanotech, and digital sectors. Provides acceleration, access to University of Minho labs, and corporate partners; backed 120+ companies. Scope: Regional (Northern Portugal).
Symbion is one of Denmark's oldest science parks and incubators, founded to support research driven startups in tech and life science. It provides office space, labs, business services, and community programs for hundreds of early stage companies, and it hosts accelerators and investor events on site. Symbion is located in Copenhagen's innovation district and acts as a bridge between universities, corporates, and founders. Many Danish startups begin their journey inside the Symbion campus.
Founded 2009. University-affiliated incubator supporting ICT and biotech startups with a 4-month validation program, follow-on acceleration, labs access, and investor network. Supported 200+ startups including SnappCar. Scope: Regional (Utrecht).